Correction: SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience.

Mangia, Alessandra; Piazzolla, Valeria; Giannelli, Anna; Visaggi, Egidio; Minerva, Nicola; Palmieri, Vincenzo; Carraturo, Immacolata; Potenza, Domenico et al. · PLoS One · 2019

Where this comes from

Record sourced from PubMed, PMID 31553772.
Also identified by DOI 10.1371/journal.pone.0223287 and PMC identifier 6760782.
No licence information is recorded for this record.
Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0215783.].

Read the full text

View on PubMed · Publisher (DOI)